The global remote patient monitoring devices market is projected to grow significantly from an estimated valuation of USD 1.3 billion in 2024 to USD 6.0 billion by 2034, registering a robust CAGR of 15.7% during the forecast period.
The demand for remote patient monitoring devices is being accelerated by several key factors, including:
- Rising Prevalence of Chronic Diseases: Increasing cases of chronic conditions such as diabetes, hypertension, and cardiovascular diseases necessitate continuous patient monitoring.
- Aging Population: A growing elderly population requires advanced solutions for regular health monitoring at home to reduce hospital visits.
- Technological Advancements: Innovations in connected devices, wearable technologies, and data analytics are enhancing the efficiency and accessibility of remote monitoring systems.
- Healthcare Cost Containment: Remote monitoring reduces the burden on healthcare facilities by enabling early detection and management of health conditions, leading to cost savings.
- Growing Adoption of Telemedicine: The integration of remote monitoring with telemedicine services is further driving its adoption as healthcare systems evolve toward digital care models.
Key Takeaways:
- The market is expected to grow from USD 1.3 billion in 2024 to USD 6.0 billion by 2034, at a CAGR of 15.7%.
- Rising prevalence of chronic diseases and an aging population are key growth drivers.
- Technological advancements in wearables and connected devices are bolstering market expansion.
- Integration with telemedicine platforms is enhancing the accessibility and adoption of remote patient monitoring solutions.
A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/remote-patient-monitoring-devices-market
Key Drivers of Market Growth
- Increasing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as diabetes, hypertension, and cardiovascular diseases is driving demand for remote monitoring solutions that facilitate continuous health tracking and timely interventions.
- Technological Advancements: Innovations in digital health technologies, including the integration of 5G connectivity and advanced data analytics, are enhancing the functionality and reliability of remote patient monitoring devices, making them more appealing to healthcare providers.
- Growing Aging Population: As the global population ages, there is a heightened need for effective monitoring solutions to manage age-related health issues, further propelling the demand for remote patient monitoring devices.
- Cost-Effectiveness: Remote monitoring reduces the need for frequent hospital visits, leading to significant cost savings for both patients and healthcare systems. This economic benefit is encouraging wider adoption among healthcare providers.
- Supportive Government Policies: Initiatives promoting telehealth and remote care, especially in the wake of the COVID-19 pandemic, are accelerating the adoption of remote patient monitoring solutions worldwide.
- Enhanced Patient Engagement: Remote monitoring devices empower patients to take an active role in managing their health, which can lead to better adherence to treatment plans and improved health outcomes.
Competitive Landscape
The remote patient monitoring devices market is extremely competitive, fueled by advances in telemedicine and rising demand for home healthcare. Koninklijke Philips N.V., and GE Healthcare are among the leading providers of comprehensive RPM solutions. Emerging firms provide novel, low cost technologies, increasing competition.
The industry is expanding steadily, fueled by technical advancements such as AI integration and wearable health technology. Regulatory support and the increased frequency of chronic illnesses help to drive market growth. Companies are spending extensively in research and development and strategic alliances to obtain a competitive advantage by improving patient outcomes and streamlining healthcare delivery.
Recent Developments
In June 2024, Koninklijke Philips N.V. has launched its next-generation AI-enabled cardiovascular ultrasound platform, which will assist speed up cardiac ultrasound analysis using proven AI technology while reducing the strain on echocardiography laboratories. The new FDA 510(k) authorized AI apps, which are integrated into Philips’ EPIQ CVx and Affiniti CVx ultrasound systems, considerably expand the company’s cardiovascular imaging and diagnosis solutions by automating measurements and speeding up workflows to increase productivity.
In May 2024, Roche announced today that the Tina-quant® lipoprotein Lp(a) RxDx test has been designated as a Breakthrough Device by the United States Food and Drug Administration (FDA) to identify patients who may benefit from a new Lp(a)-lowering medication that is presently being developed. Lp(a) is emerging as a significant, yet underappreciated, prospective risk factor for cardiovascular disease, and a major public health concern.
Remote Patient Monitoring Devices Market by Category
By Product Type:
In terms of product type, the market encompasses vital sign monitors (heart rate monitors (ecg) blood pressure monitors, respiratory rate monitors, brain monitoring (eeg), temperature monitors, pulse oximeters and others) and special monitors (blood glucose monitors, fetal heart monitors, multi-parameter monitors (mpm), anaesthesia monitors, prothrombin monitors and others.
By Application:
Application segment is categorized into cardiovascular diseases, diabetes, cancer, hypertension, infections, bronchitis, dehydration, sleep disorder, weight management & fitness monitoring and others.
By End User:
The end user of remote patient monitoring devices hospital based patients, homecare, ambulatory patients and others.
By Region:
As per region, the industry is divided into North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Hysteroscopy Procedures Market
Insulin Pumps Market
Medical Spa Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube